Insight Molecular Diagnostics Inc. Logo

Insight Molecular Diagnostics Inc.

Develops molecular diagnostic tests for precision medicine in transplantation and oncology.

IMDX | US

Overview

Corporate Details

ISIN(s):
US68235C1071
LEI:
Country:
United States of America
Address:
2 INTERNATIONAL PLAZA DR., SUITE 510, 37217 NASHVILLE

Description

Insight Molecular Diagnostics Inc. (iMDx) is a precision diagnostics company that develops and commercializes molecular diagnostic tests. The company focuses on advancing precision medicine in transplantation and oncology. Its solutions are designed for researchers, clinicians, and healthcare systems to enable early detection, guide treatment, and accelerate discovery. Key products include blood-based tests for transplant monitoring that quantify donor-derived cell-free DNA (dd-cfDNA) to assess organ health following transplantation. In oncology, the company provides tools to support cancer immunotherapy guidance. iMDx aims to deliver accurate and scalable diagnostic tools that provide clear, actionable insights for clinical and research decision-making.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Insight Molecular Diagnostics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Insight Molecular Diagnostics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Insight Molecular Diagnostics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Option Care Health, Inc. Logo
An independent provider of home and alternate site infusion services and therapies.
United States of America
OPCH
PANGAEA Oncology Logo
A medical services company specializing in precision oncology for patients and pharma.
Spain
PANG
An integrated resort and hospitality company operating foreigner-only casinos and hotels.
South Korea
034230
Pennant Group, Inc. Logo
A holding company providing home health, hospice, home care, and senior living services.
United States of America
PNTG
Personalis, Inc. Logo
Offers advanced cancer genomics and data analysis for personalized therapies.
United States of America
PSNL
Pharmarise Holdings Corporation Logo
A holding company that manages and operates a network of dispensing pharmacies.
Japan
2796
Precipio, Inc. Logo
A cancer diagnostics company offering clinical services and proprietary products.
United States of America
PRPO
PREDILIFE Logo
Develops AI-powered solutions to assess individual risk for major diseases.
France
ALPRE
Qol Holdings Co.,Ltd. Logo
A holding company operating in the pharmacy, pharmaceutical, and BPO sectors.
Japan
3034
QUEST DIAGNOSTICS INC Logo
Provider of diagnostic information and a broad range of clinical laboratory services.
United States of America
DGX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.